DTL
MRSN

Dynamic Technology Lab’s Mersana Therapeutics MRSN Stock Holding History

Dynamic Technology Lab’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-724
Closed -$34K – 1204
2024
Q3 		$34K Buy
+724
New +$31.9K ﹤0.01% 964
2023
Q3 		– Sell
-515
Closed -$42K – 1181
2023
Q2 		$42K Sell
515
-222
-30% -$32.5K 0.01% 932
2023
Q1 		$76K Sell
737
-244
-25% -$34.2K 0.01% 988
2022
Q4 		$144K Sell
981
-287
-23% -$48.5K 0.01% 960
2022
Q3 		$214K Buy
1,268
+435
+52% +$70.7K 0.02% 939
2022
Q2 		$96K Buy
833
+152
+22% +$14.3K 0.01% 992
2022
Q1 		$68K Sell
681
-634
-48% -$74.1K 0.01% 1026
2021
Q4 		$204K Buy
+1,315
New +$256K 0.02% 956
2021
Q3 		– Sell
-793
Closed -$269K – 1330
2021
Q2 		$269K Buy
+793
New +$300K 0.03% 833
2020
Q2 		– Sell
-621
Closed -$91K – 1199
2020
Q1 		$91K Buy
+621
New +$109K 0.02% 904
2019
Q4 		– Sell
-471
Closed -$19K – 1183
2019
Q3 		$19K Buy
+471
New +$34.2K ﹤0.01% 908

Other funds holding MRSN

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Dynamic Technology Lab's MRSN Position: Q4 2024 in Review

Dynamic Technology Lab sold out of Mersana Therapeutics (MRSN) in Q4 2024, closing a stake of 724 shares — an estimated $34K sold.

Dynamic Technology Lab first reported a position in MRSN in Q3 2019 and held it in 11 quarters. The position peaked at $269K in Q2 2021. 128 funds tracked by Wall St. Rank hold MRSN as of Q4 2024.

  • Dynamic Technology Lab reported no remaining Mersana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 724 Mersana Therapeutics shares in Q4 2024, an estimated $34K.
  • Dynamic Technology Lab first reported a position in Mersana Therapeutics in Q3 2019 and held it in 11 quarters.
  • Dynamic Technology Lab's Mersana Therapeutics position peaked at $269K in Q2 2021.
  • 128 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q4 2024.

Based on Dynamic Technology Lab's 13F filing for Q4 2024, filed 13 Feb 2025.